Understanding Angiotensin II Receptor Blockers (ARBs): Uses, Benefits, Risks, and Guidance

ARBs (angiotensin II receptor blockers) are oral tablets usually taken once daily. Common side effects include fatigue, dizziness, and headache.

Consult your physician to determine whether an ARB is appropriate for your health needs.

The U.S. Food and Drug Administration (FDA) has approved ARBs for several cardiovascular conditions, including hypertension, heart failure, post‑myocardial‑infarction therapy, and diabetic nephropathy.

Off‑label uses

In practice, clinicians sometimes prescribe ARBs for conditions that are not FDA‑approved, based on emerging evidence. Examples include certain forms of chronic kidney disease and specific types of proteinuria.

ARBs work by blocking the angiotensin II receptors on blood‑vessel, heart, and kidney cells. Angiotensin II normally binds to these receptors, causing vessels to constrict, raising blood pressure, and promoting salt‑water retention. By preventing this binding, ARBs keep vessels relaxed, lower blood pressure, and reduce fluid retention.

Vs. ACE inhibitors

Angiotensin‑converting‑enzyme (ACE) inhibitors lower blood pressure by reducing the production of angiotensin II. ARBs achieve a similar result by blocking the hormone’s action at its receptor. Physicians may prefer ARBs when patients cannot tolerate ACE inhibitors because of cough or angio‑edema.

Several ARBs are available, often under both generic and brand names. Common agents include:

• Losartan (Cozaar)
• Valsartan (Diovan)
• Irbesartan (Avapro)
• Candesartan (Atacand)
• Olmesartan (Benicar)

Some formulations combine an ARB with a thiazide diuretic (e.g., hydrochlorothiazide‑valsartan / Diovan HCT, hydrochlorothiazide‑losartan / Hyzaar) to enhance blood‑pressure control.

Typical dosing starts with a low once‑daily tablet; the dose may be titrated upward if blood‑pressure targets are not met. Certain patients, such as those with heart failure, might require twice‑daily dosing.

Potential side effects range from mild to serious:

• fatigue
• dizziness
• headache
• fainting
• shortness of breath
• diarrhea
• vomiting
• back pain
• leg swelling
• elevated potassium levels

Rarely, users may experience:

• acute kidney injury
• severe allergic reactions

Drug interactions are important to monitor. Do not combine ARBs with ACE inhibitors, as this can increase the risk of hyper‑kalemia, hypotension, and kidney damage. Non‑steroidal anti‑inflammatory drugs (NSAIDs) such as ibuprofen (Advil) or naproxen (Aleve) may also raise the chance of acute kidney injury when taken with an ARB and a diuretic.

Always inform your healthcare provider about prescription drugs, over‑the‑counter medications, supplements, or herbal products you are using.

Pregnancy warning: The FDA requires a boxed warning for ARBs during pregnancy. Exposure can harm fetal development and increase the risk of adverse outcomes. Women who are pregnant, planning pregnancy, or may become pregnant should avoid ARBs and discuss alternative therapies with their clinician.

Patients with diabetes who are prescribed aliskiren (Tekturna) should not take an ARB concurrently, due to an increased risk of renal complications.

Cancer risk has been debated. A 2010 meta‑analysis of five trials suggested a possible link, but a comprehensive FDA review of >30 studies in 2011 found no consistent association. Subsequent research is mixed: a large 2021 Korean cohort indicated a protective effect, while a 2022 trial‑level analysis reported a modest increase in long‑term cancer risk. Ongoing studies aim to clarify this issue.

In summary, ARBs are effective for managing high blood pressure, heart failure, post‑MI care, and diabetic kidney disease. Discuss your full medical history, current medications, and any concerns—such as cancer risk or pregnancy— with your physician to decide whether an ARB is right for you.